![](/img/cover-not-exists.png)
A randomized trial confirming the efficacy of reduced dose recombinant tissue plasminogen activator in a Chinese myocardial infarction population and demonstrating superiority to usual dose urokinase: The TUCC trial
Allan M. Ross, Runlin Gao, Karin S. Coyne, Jilin Chen, Kangbao Yao, Yuejin Yang, Xuewen Qin, Shubin Qiao, Min YaoVolume:
142
Year:
2001
Language:
english
DOI:
10.1067/mhj.2001.116963
File:
PDF, 79 KB
english, 2001